Quantitative study of tissue-engineered cartilage with human bone marrow mesenchymal stem cells

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Cell Biology

Background:

• Cartilage tissue engineering aims to repair damaged cartilage using cells and scaffolds.
• Human mesenchymal stem cells (hMSCs) are a promising cell source for cartilage regeneration.
• Establishing quantitative standards for hMSC use is crucial for clinical translation.

Purpose of the Study:

• To assess the feasibility of cartilage tissue engineering with hMSCs.
• To determine the quantitative relationship between hMSC numbers and engineered cartilage outcomes.
• To establish quantitative standards for hMSC seed cells in cartilage engineering.

Main Methods:

• Human mesenchymal stem cells (hMSCs) were cultured, expanded, and characterized.
• In vitro chondrogenesis was induced in hMSCs.
• hMSCs were seeded onto polyglycolic acid scaffolds and implanted in nude mice for 10 weeks.
• Histologic and immunochemical analyses were performed on harvested implants.

Main Results:

• Optimal chondrogenesis induction for hMSCs was achieved in 21 days with a 95% induction rate.
• Sufficient hMSCs for engineering 1 cm² of 3-mm thick cartilage can be derived from 0.07-0.14 mL bone marrow after 4 passages.
• Expanded hMSCs maintained high purity (>95%) through passage 4.

Conclusions:

• Quantitative standards for hMSC seed cells in cartilage tissue engineering were successfully established.
• These standards provide a valuable framework for future clinical cartilage repair strategies.
• The study demonstrates the potential of hMSCs for engineering functional cartilage tissue.